Promethazine (PMZ) is the antimotion sickness drug of choice in the U.S. Space Shuttle program; however, virtually nothing is known about the bioavailability and performance effects of this drug in the microgravity environment. PMZ has detrimental side effects on human performance on Earth that could affect Shuttle operations. In a recent ground-based study we examined: 1) the effects of promethazine (PMZ) on Shuttle landing performance using the portable inflight landing operations trainer (PILOT), and 2) saliva and urine samples to determine the pharmacokinetics of PMZ. The PILOT performance data is presented here.
Effects of Promethazine on Performance During Simulated Shuttle Landings
1999-01-01
Conference paper
No indication
English
Weather impacts upon Space Shuttle landings
AIAA | 2000
|Weather Impacts Upon Space Shuttle Landings
British Library Conference Proceedings | 2000
|Smart Software to Improve Shuttle Landings
Online Contents | 1998